Yew Bio Pharm Cash Flow - Annual (OTCMKTS:YEWB)

Add to My Stocks
$0.33 $0 (0%) YEWB stock closing price Feb 21, 2017 (Closing)

The Yew Bio Pharm cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. Financials statements like the income statement and balance sheet show that the company has Yew Bio Pharm profits and Yew Bio Pharm debt, while the cash flow statement provides details of cash flow movments. Yew Bio Pharm cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Yew Bio Pharm had cash and cash equivalents of $0.48M at the beginning of the year and $0.68M at year end for 2015.   Yew Bio Pharm had an outflow of $5.48M from operating activities, $6.29M inflow due to financing activities, and $0.08M gain due to investing activities for 2015. View details of Yew Bio Pharm cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011
Yew Bio Pharm Net Income Cash Flow
5.28M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization Cash-Flow7.74M0.68M0.56M0.56M0.47M
Net Increase (Decrease) in Assets Liabilities-15.43M-1.35M-0.01M-4.59M-0.15M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net1.03M0.5M-2.24M0.01M
Yew Bio Pharm Net Cash from (used by) Operating Activities
-1.37M4.11M4.44M0.41M4.37M
Increase (Decrease) in Prop Plant And Equipment-0.02M--0.29M-0.31M-0.17M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities-2.33M-2.44M-3.39M-0.39M-5.51M
Yew Bio Pharm Net Cash from (used by) Invesment Activities
-2.36M-2.44M-3.69M-0.7M-5.68M
Issuance (Purchase) of Equity Shares-----
Issuance (Repayment) of Debt Securities-----
Increase (Decrease) in Bank & Other Borrowings3.21M----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities
Yew Bio Pharm Net Cash from (used by) Financing Activities
3.96M-2.33M--0.06M0.08M
Effect of Exchange Rate Changes on Cash-0.03M-0.01M0.02M0.01M0.11M
Yew Bio Pharm Net Change in Cash & Cash Equivalents
0.19M-0.67M0.77M-0.34M-1.11M
Cash & Equivalents at Beginning of Year0.48M1.15M0.38M0.73M1.85M
Cash & Equivalents at Year End0.68M0.48M1.15M0.38M0.73M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

Yew Bio Pharm stock price history provides insight into historical stock price fluctuations, and Yew Bio Pharm stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Yew Bio Pharm had a Net Change in Cash and Cash Equivalents of $0.19M for the latest year 2015. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Yew Bio Pharm stock price , albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Yew Bio Pharm decreased its cash from operating activities to $5.48M in 2015. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: Yew Bio Pharm generated $0.08M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $3.96M for Yew Bio Pharm. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin
0.01